SCHEMBL24072392

SCHEMBL24072392

CCOc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.61
▸ GAA P10253 2/20 0.61
▸ LMNA P02545 2/20 0.61
▸ MAPK1 P28482 2/20 0.60
▸ ALOX15 P16050 1/20 0.60
▸ USP2 O75604 1/20 0.58
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ HPGD P15428 1/20 0.57
▸ RAB9A P51151 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ TSHR P16473 1/20 0.55
▸ MAPT P10636 2/20 0.52
▸ HCRTR1 O43613 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ KCNMA1 Q12791 1/20 0.50
▸ RXFP1 Q9HBX9 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ KCNK3 O14649 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13045038 0.88 RAB9A (0.58) ALDH1A1GAALMNAMAPK1MEN1
SCHEMBL10287240 0.86 ALDH1A1 (0.45) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL13044208 0.86 ALDH1A1 (0.65) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24073805 0.85 NPC1 (0.47) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24074428 0.85 NPC1 (0.53) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24073955 0.84 ALDH1A1 (0.43) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24074067 0.84 ALDH1A1 (0.43) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24074515 0.84 KAT2B (0.44) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL24074427 0.84 NPC1 (0.52) ALDH1A1GAALMNAMAPK1ALOX15
SCHEMBL26357857 0.84 NPC1 (0.54) ALDH1A1GAALMNAMAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885GAA 2196/4885LMNA 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback